OPGx-003

N/A

Report date: 2023/10/26 16:59:49

Base Information

Drug NameOPGx-003
Drug Alias NameOPGx-003
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 gene transference
TargetsNicotinamide/nicotinic acid mononucleotide adenylyltransferase 1
Therapy Area/IndicationsLeber Congenital AmaurosisLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOpus Genetics IncShanghai Cell Therapy Group Co Ltd
Inactive CompaniesN/A
Active IndicationsLeber Congenital AmaurosisLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A